Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Clinical Lab > Clinical Chemistry - Liver and GI Function, Lipid Metabolism, and Cardiovascular Disease > Flashcards

Clinical Chemistry - Liver and GI Function, Lipid Metabolism, and Cardiovascular Disease Flashcards

1
Q

Liver Vessel Anatomy

A

Hepatic Artery - Blood in from Aorta
Portal Vein - blood in from GI tract (to detoxify blood prior to entering systemic circulation)
Common Bile Duct - transports bile to Gall Bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Kupffer Cell

A

Stationary liver macrophages that “filter” portal (GI) blood of bacteria, debris, foreign proteins, toxins, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hemoglobin Processing

A

RBCs broken down in reticuloendothelial system (spleen)

  • Fe transported by transferrin to marrow/storage
  • Globin proteins recycled to amino acids
  • Heme oxidized to biliverdin -> biliverdin reduced to bilirubin -> bilirubin bound to albumin and transported to liver

Bilirubin conjugated to glucoronide and excreted into canaliculi to gb/duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GI Metabolism of Bilirubin

A

Conjugated bilirubin is metabolized by intestinal flora to urobilinogen (colorless). Urobilinogen is then oxidized (80%) to urobilin which gives stool brown color

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Block of bile duct

A

Blockage causes back up of bilirubin, not allowing formation of urobilin. Patients present with pale stool. Can be sign of pancreatic tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bile Acids

A

Formed by metabolism of cholesterol - can be administered to lower cholesterol
Emulsifies dietary fat for lipase hydrolysis.
Increased in liver dz, but test is inefficient (dz can be indicated by other tests and bile acids offer no other dx info)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

First Pass Metabolism

A

Portal vein brings absorbed molecules to liver prior to general circulation. Liver is able to metabolize toxins before being released to rest of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Liver Function Test (LFT)

A 
"Hepatic function panel"
Total Protein
Albumin
AST 
ALT
ALP
Total bilirubin
Direct bilirubin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Total Protein

A

Biuret reaction: Cu reacts with peptide backbone in alkaline medium
RR: 6.0-8.0 mg/dL
Increased: dehydration, increased synthesis (MM), extended tourniquet time
Decreased: low synthesis (liver dz, malnutrition), increased loss (kidney dz, burns,)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Albumin

A

Bromcresol green or purple rxn: BCG overestimates in hemolysis, BCP underestimates in renal dz&bilirubinemia
RR: 3-5-5.0 gm/dL
Increased: dehydration, tourniquet time
Decreased: liver dz, renal, GI, burns, nutritional deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aminotransferases

A

ALT & AST
Enzymes found within hepatocyte involved in amino acid metabolism.
Not specific for liver function but a marker of cellular integrity.
Measured by kinetic coupled enzyme rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ALT

A

Alanine aminotransferase
Kinetic assay measuring decreased absorbance at 340 nm (NADH -> NAD+)
Somewhat liver specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AST

A

Aspartate aminotransferase
Kinetic assay measuring decreased absorbace at 340 nm (NADH -> NAD+)
Poor tissue specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ALP

A

Alkaline Phosphatase
Associated with biliary canaliculi - not tissue specific, liver/bone/kidney isoforms (post-trans glycosylation) plus intestinal and placental isoenzymes -> may need source determination if elevated
Biliary obstruction induces ALP synthesis
Not a marker of cellular integrity
Measured by hydrolysis of p-nitrophenyl phosphate at pH 10.3 (increasing rate rxn)
Activity increases 2%/day in fridge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GGT (Gamma-glutamyltransferase)

A

Not tested for in LFT

GGT in plasma is primarily liver-related - more specific marker of hepatobiliary dz than ALP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Forms of bilirubin

A

Unconjugated: Circulates tightly bound to albumin to protect against uptake by fatty tissues (brain), poorly soluble in plasma
Conjugated: Circulates freely in plasma, very soluble, mono/di-glucaronyl
Delta: monoglucoronide bound to albumin rather than second glucoronide; results from prolonged bili elevations, cannot be easily measured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Measurement of bilirubin

A

Jendrassik-Grof method:
Sulfanilic acid reacts with soluble bili to form colored product –> Direct Bili (conj + delta)
Adding caffeine-benzoate enhances solubility of unconj bili –> Total Bili
Assay photosensitive and affected by hemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pre-Hepatic Jaundice

A

Increased bili load to liver:

  • hemolytic processes/ineffective erythropoiesis (transfusion rx, B12 def.), internal bleeding
  • primary unconjugated bilirubin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hepatic Jaundice

A

Primary liver defect in conjugating bilirubin due to congenital defects or active liver disease

GILBERTS SYNDROME: benign, defect in ugt1a1 (conj. enzyme), increase in u-c bili
CRIGLER-NAJJAR SYNDROME: conjugation defect (high u-c bili), type 1 fatal (total absence) type 2 not (partial absence)
DUBIN JOHNSON/ROTOR SYNDROMES: defect in transport of conj bili to bile; increase in conj bili, benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Neonatal Jaundice

A

Normal for short time after birth due to high RBC turnover and glucoronyl enz immaturity

  • KERNICTERUS: increase of u-c bili can cross into brain when levels exceed albumin binding capacity, death/brain injury
  • measured by spec in babies (vitA/carotene interferes in adults) or POC device through skin (skin color interference)
  • Bhutani Nomogram shows risk zones of bili vs. age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Post-Hepatic Jaundice

A

Decreased excretion of conj bili to bile

  • increase in direct bili, pale stool (low urobilinogen), bilirubinuria (filtered by kidney)
  • intrahepatic due to liver dz
  • extrahepatic due to physical block of biliary ducts (gall stones,tumors) –> CHOLESTASIS “Obstructive Jaundice”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ammonia

A

Liver responsible for getting NH3 from protein metabolism and GI bacteria

  • converts to urea in urea cycle
  • impaired by hepatitis & cirrhosis, increased by GI bleed or severe liver failure
  • measurement: glutamate dehydrogenase converts nh3, a-KG, NADPH to glutamate and NADH (dec. abs at 340nm)
  • perform stat due to instability, sample iced, beware of airborne contamination (cleaner)
  • very small amounts, measured in mcmol
23
Q

Acute Hepatitis

A

Inflammation of liver affecting hepatocytes

  • elevated ALT, AST levels -> ALP, GGT elevations mild, bili high in prolonged dz
  • ALCOHOLIC: lower AST, ALT than in viral (peaks 50-125, 100-300)
  • VIRAL: AST:ALT less than 1, levels high (peaks 300-800, 400-1200)
  • ISCHEMIC/TOXIC: hypoxic tissues causes very high AST:ALT (>1) peaks 100-10k, 800-6000, prolonged coag tests
24
Q

Obstructive Jaundice (Cholestasis)

A

Lower levels of AST, ALT with progressive increase in ALP & GGT
Direct bilirubin increase parallels ALP/GGT rise
Caused by bile duct obstruction (stones), intrahepatic hepatitis, tumors/metastases, infiltration (amyloid, leukemia)

25
Q

Chronic Hepatitis

A

Viral (hep B/C)
NASH (Non-Alcoholic Fatty Liver dz): common in patients with metabolic syndrome
Hemochromatosis: increased iron uptake
Wilson’s Ds: copper accumulation

26
Q

Cirrhosis

A

Liver fibrosis due to chronic hepatits or cholestasis –> portal hypertension (fluid buildup, GI bleeds), edema, decreased LFT

Scarring -> fibrous tissue -> contracts and increases resistance

27
Q

Pancreas - Endocrine function

A

“secrete into bloodstream” - Islets of Langerhans

  • Insulin: lowers glucose
  • Glucagon: raises glucose
  • Somatostatin: down-regulates others
  • Pancreatic polypeptide: multiple functions
  • Gastrin: pathologically (normally from stomach)
28
Q

Pancreas - Exocrine function

A

“secrete into space” - Acinar cells secrete into ducts

  • Bicarbonate-rich fluid to neutralize gastric acidity (secretin)
  • Digestive enzymes as proenzymes (CKK- cholecystokinin)
29
Q

Pancreatitis

A

Inflammation of the pancreas due to autodigestion by enzymes

  • reflux of bile or duodenal contents (biliary obstruction, alcoholism, hyperlipid/calcemia/pth
  • signs & symptoms: abdom pain, hypovolemia (intra-abdominal fluid), hypocalcemia (lipolysis of peri-pancreatic fat & soap precipitation)

soap: fat + lye to form calcium salts

30
Q

Amylase

A
  • hydrolyzes 1,4-glycoside bonds in starch
  • secreted by pancreatic acinar cells and salivary glands (1/3:2/3)
  • Calcium cofactor, Chloride enhances activity
  • high in pancreatitis; rises in 5-8 hrs, peaks 12-72 hrs, elevated 3-5 days
31
Q

Amylase assay

A

Use artificial substrate, measure kinetically (405-415nm), RR method specific

  • P-amylase measured by Ab inhibition of S-amylase (substrate will only be able to bind to p-amy)
  • Values 3-5x ULN more specific for pancreatitis
  • elevations also from: panc trauma, obstruction/peptic ulcer/gastrities (high p-amy), GU dz (high s-amy), opiates, renal dz
32
Q

Lipase

A
  • hydrolyzes trigs to 2-monoglycerides
  • present in pancreas, stomach, intestine (pancreas 2000x other tissues)
  • w/pancreatitis: increases 4-8hrs, peaks 24 hrs, decreases 8-14 days
  • peaks first, followed by amylase
33
Q

Lipase Assays

A
  • hydrolysis of glycerides to glycerol (detected)
  • hydrolysis of triolein emulsion with decreasing turbidity
  • measured kinetically
  • specificity to pancreatic lipase enhanced by addition of colipase and bile salts -> more specific for pancreatic origin if >5x ULN
  • greater sensitivity/specificity than amylase so preferred
34
Q

Cystic Fibrosis

A
  • Autosomal recessive disorder resulting in altered mucus secretion in lungs and pancreas
  • CTFR mutation: abnormal Na/Cl transport across membranes
  • May present as: intestinal obstruction (newborns), recurrent pulmonary infections (child), malabsorption (adults)
35
Q

Pancreatic tumors

A
  • Insulinoma: severe hypoglycemia (endocrine)
  • Glucagonoma: hyperglycemia, lipolysis
  • VIPoma: vasoactive intestinal polypeptide, severe diarrhea (pancreatic cholera)
  • Zollinger-Ellison syndrome (gastrinoma): HCL hypersecretion, recurring peptic ulcer
  • Adenocarcinoma (panc. cancer): CA 19-9 non specific marker, 5yr survival 6%, high fatality
36
Q

GI Function: Stomach

A

Secretion of:

  • HCL: vagus nerve stimulated by sight/smell of food, gastrin secreted when full (gastric distension)
  • Pepsinogen: inactive zymogen converted to pepsin when pH
37
Q

GI Function: Intestine

A

Small Intestine:
- Duodenum: addition of digestive fluid
- site of most digestion and nutrient absorption
- carbs as monosaccs, proteins as AAs and dipeptides, lipids as glycerol/fatty acids/cholesterol
Large Intestine:
- Primary site of water absorption

38
Q

Stomach Disorders

A
  • Gastric ulcers: NSAIDS (decrease mucus production), H. pylori attaches to mucosal cells
  • Zollinger-Ellison: gastrinoma leads to excess acid and diarrhea
  • Stomach cancer: 6x incidence w/ H. pylori (Ab tested in serum, Ag in stool, Urea breath test w/labeled CO2 pill to indicate active urea hydrolysis in stomach)
39
Q

Intestinal Disease

A

Maldigestion: decreased food breakdown, lack of HCl, cholestasis, pancreatic insufficiency

Malapsorption: decreased absorption in small intestine, can arise from maldigestion, loose/greasy stools
- Xylose absorption test: non-metabolizable carb given orally, tested in urine and blood to determine malabsorption

40
Q

Celiac Disease

A
  • Auto-immune ds of small intestine: Ab against gliadin (gluten protein)
  • diagnosed by biopsy or serology*: anti-tissue transglutaminase (TTG-IgA) -> 10% patients have IgA deficiency that can give false neg (total IgA done first)
41
Q

Inflammatory Bowel Disease (IBD)

A

autoimmune w/ genetic component
Ulcerative Colitis:
- limited to colon (lg bowel), mucosal lining
- present as pain & diarrhea
- measured Atypical pANCA -> ind. immunofluorescence
Crohn’s Disease
- commonly sm. bowel but can affect all of GI tract, entire tract wall
- pain & diarrhea plus malabsorption
- measured ASCA -> EIA for IgG/IgA

42
Q

Colorectal (Colon) Cancer

A
  • 2nd leading cause of cancer death
  • Fecal occult blood: Guaiac method detects peroxidase activity of Hgb, Immunochem method detects hgb with antibodys
  • Carcinoembryonic Antigen (CEA): tumor marker used to monitor disease not used for dx
43
Q

Lipoproteins: Chylomicrons

Exogenous Pathway

A
  • produced in the intestine from absorbed lipids (gotten from diet)
  • trigs hydrolyzed by pancreatic lipase into glycerol & fatty acids -> intestinal cells re-form trig plus apo B-48 (truncated B-100 VLDL protein)
  • transferred to blood via sup vena cava & lymphatic system, hydrolized by endothelial lipoprotein lipase in muscle & fat tissues, remnants taken up by liver
  • large and scatter light: post-prandial turbidity
  • LIGHTEST OF LPs -> CREAM LAYER
44
Q

Lipoproteins: VLDL

Endogenous Pathway

A
  • Trig-rich lipoprotein with B-100
  • Produced in liver from hepatic synthesis of trigs following excess intake of carbs/satfat/transfat
  • Trigs hydrolyzed by ELL in muscle/fat, become IDL before being converted to VLDL by hepatic lipase
  • large and scatter light like chylomicrons but DO NOT float in stored plasma
45
Q

Lipoproteins: LDL

Bad Cholesterol

A
  • considered atherogenic (hardening of arteries)
  • formed from the removal of trigs from VLDL
  • LDL receptors for uptake by liver and peripheral cells
  • small size allows penetration into EC space of blood vessel walls -> become oxidized, phagocytized by macrophages turn into FOAM CELLS
46
Q

LDL Cholesterol: Lipoprotein (a)

A
  • LDL particle with apo(a) bound to B-100
  • significant homology with plasminogen a fibrinolytic enzyme precursor -> can compete with plasminogin, preventing clot lysis
  • genetically determined, responds poorly to therapy
47
Q

Lipoproteins: HDL

Good Cholesterol

A
  • Liver and intestine synthesize nascent HDL -> accumulates cholesterol esters internally “trapped”, reverse cholesterol transport
  • Liver selectively removes cholesterol esters, metabolized to bile acids and secreted to bile
  • CETP transfers cholesterol from HDL to LDL, from tissues to liver for metabolism
  • higher in women due to high estrogen (lowers post-menopause)
48
Q

Lipoprotein Metabolism Summary

A
  • Chylomicrons transport dietary trigs from intestine to tissues (lymph, blood, muscle, fat)
  • VLDL transports endogenous trigs from liver to tissues for energy or storage (becomes LDL from IDL)
  • Cholesterol synthesized in liver is transported to tissues via VLDL -> IDL -> LDL
  • HDL picks up cholesterol from peripheral cells/lipoproteins and transports to liver for excretion in bile
49
Q

Lipid Panel

A

First line of testing for cv risk

  • Trigs
  • Total Chol
  • HDL Chol
  • Calculated LDL Chol

requires 9-12 hr fasting to calculate LDL to eliminate presence of chylomicrons

50
Q

Trig measurement

A

Most assays are glycerokinase based w/ varying secondary rxn
Interference from bili, hemolysis, ascorbate (peroxidase rxn)
Serum glycerol induces error (in diabetes, stress, iv, etc) assays where glycerol is blanked available

51
Q

Cholesterol measurement (total, HDL, LDL)

A

All assays enzymatic
HDL: precipitation of apo(b) containing lipoproteins with selective blocking reagents, reagents will react w/HDL only
LDL: calculated estimate with Friedewald equation
LDL = Chol - HDL Chol - Trig/5
- trig/5 represents VLDL lps
Direct LDL: selective blocking reagents, no fasting required, expensive

52
Q

Development of Atherosclerosis

A
  • Endothelial lining of arteries is “invisible” to coag factors
  • Hyperlipidemia allows LDL into subendothelium, LDL oxidizes (foam cells) and induces inflammatory process**
  • Fibrous cap develops over the plaque (continued proliferation of sm muscle cells) hides endothelial injury
  • long standing process, clot forms when endothelial lining ruptures and exposes foci/injury markers
53
Q

C-Reactive Protein

A
  • APR produced by the liver in response to injury, non-specific but sensitive marker of coronary inflammation
  • Prognostic value for coronary artery dz and subsequent coronary syndrome
  • measured by nephelometry or turbidimetry
  • Independent of cholesterol as risk factor, but related

Clinical Lab (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions